Does Anamorelin have analgesic effect?

Anamorelin (Anamorelin) is mainly a gastric motility drug and is widely used to treat malignant tumor-related weight loss and muscle loss. According to publicly released information, anamulin's primary efficacy does not include pain relief.

Anamorelin improves the loss of appetite in patients with cachexia by stimulating the appetite center, thereby increasing food intake and helping patients take in more nutrients to restore body functions and immunity. This is one of its most important effects and has significant effects on patients suffering from weight loss and muscle loss due to cancer or other chronic diseases.

In addition to increasing appetite and weight, anamorelin also promotes the body's metabolic functions, including protein synthesis, energy metabolism, and muscle production. This helps improve the patient's muscle function and physical strength levels.

Cachexia patients are often accompanied by physical weakness and low mental status. The use of anamulin can significantly improve the patient's quality of life and mental status. By increasing appetite, gaining weight, and improving physical strength and mental state, patients can feel more energy and motivation.

Anamorelin can also enhance immunity by improving the body's nutritional status and metabolic function, improve patients' disease resistance, and reduce the risk of infection.

Although anamorelin has shown significant efficacy in improving many aspects of cancer cachexia, according to currently published information, it does not have analgesic effects. Pain relief often requires other types of medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) available over-the-counter or opioids available by prescription.